Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

10.90
Delayed Data
As of May 26
 -0.20 / -1.80%
Today’s Change
7.86
Today|||52-Week Range
25.56
-26.55%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues63.9M35.5M52.3M89.7M
 
 
 
 
 
Depreciation And Amortization7.5M8.2M8.7M8.7M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses116.5M136.9M142.9M165.4M
 
 
 
 
 
Research And Development80.3M104.0M106.5M126.0M
 
 
 
 
 
Total Operating Expenses124.0M145.1M151.6M174.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-60.1M-109.6M-99.4M-84.4M
 
 
 
 
 
Other Expenses220.0K233.0K248.0K313.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-58.6M-108.4M-98.6M-83.3M
 
 
 
 
 
Net Income-58.6M-108.4M-98.6M-83.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS50.4M50.9M51.7M63.1M
 
 
 
 
 
Shares To Calculate EPS Diluted50.4M50.9M51.7M63.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.16-$2.13-$1.91-$1.32
 
 
 
 
 
EPS Diluted-$1.16-$2.13-$1.91-$1.32